Courèche Kaderbhaï

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa et al. · Science · 2017 · 5.2K citations

Antibiotic Use Does Not Appear to Influence Response to Nivolumab

Courèche Kaderbhaï, Corentin Richard, Jean David Fumet et al. · Anticancer Research · 2017 · 106 citations · Full text

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Hossein Borghaei, Filippo de Marinis, Daphne W. Dumoulin et al. · Annals of Oncology · 2023 · 78 citations · Full text

Nivolumab Versus Docetaxel, Medicine, Pharmacology +7

Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma

Aurélie Bertaut, Caroline Truntzer, Rachid Madkouri et al. · Oncotarget · 2016 · 70 citations · Full text

Neuro-oncology, Bevacizumab Efficacy, Bevacizumab Use +14

Use of dedicated gene panel sequencing using next generation sequencing to improve the personalized care of lung cancer

Courèche Kaderbhaï, Romain Boidot, Françoise Beltjens et al. · Oncotarget · 2016 · 29 citations · Full text

Engineering, Pathology, Tumor Biology +20